Japan Financial Statements From 2010 to 2026
| JMDMF Stock | USD 3.01 0.00 0.00% |
Check Japan Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Japan Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Japan financial statements analysis is a perfect complement when working with Japan Medical Valuation or Volatility modules.
Japan |
Japan Medical Dynamic Company Return On Asset Analysis
Japan Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Japan Medical Return On Asset | 0.0496 |
Most of Japan Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Japan Medical Dynamic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Japan Medical Dynamic has a Return On Asset of 0.0496. This is 100.57% lower than that of the Healthcare sector and 100.27% lower than that of the Medical Devices industry. The return on asset for all United States stocks is 135.43% lower than that of the firm.
Japan Medical Dynamic Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Japan Medical's current stock value. Our valuation model uses many indicators to compare Japan Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Japan Medical competition to find correlations between indicators driving Japan Medical's intrinsic value. More Info.Japan Medical Dynamic is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.65 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Japan Medical Dynamic is roughly 1.53 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Japan Medical's earnings, one of the primary drivers of an investment's value.About Japan Medical Financial Statements
Japan Medical stakeholders use historical fundamental indicators, such as Japan Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Japan Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Japan Medical's assets and liabilities are reflected in the revenues and expenses on Japan Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Japan Medical Dynamic. Please read more on our technical analysis and fundamental analysis pages.
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company was incorporated in 1973 and is headquartered in Tokyo, Japan. Japan Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 474 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Japan Pink Sheet
Japan Medical financial ratios help investors to determine whether Japan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Japan with respect to the benefits of owning Japan Medical security.